These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 2742363

  • 1. Induction of aromatic-L-amino acid decarboxylase by decarboxylase inhibitors in idiopathic parkinsonism.
    Boomsma F, Meerwaldt JD, Man in 't Veld AJ, Hovestadt A, Schalekamp MA.
    Ann Neurol; 1989 Jun; 25(6):624-8. PubMed ID: 2742363
    [Abstract] [Full Text] [Related]

  • 2. Treatment of idiopathic parkinsonism with L-dopa in the absence and presence of decarboxylase inhibitors: effects on plasma levels of L-dopa, dopa decarboxylase, catecholamines and 3-O-methyl-dopa.
    Boomsma F, Meerwaldt JD, Man in't Veld AJ, Hovestadt A, Schalekamp MA.
    J Neurol; 1989 May; 236(4):223-30. PubMed ID: 2760634
    [Abstract] [Full Text] [Related]

  • 3. [The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].
    Podiwinsky F, Mentasti M, Riederer P, Birkmayer W.
    Wien Klin Wochenschr; 1979 May 11; 91(10):332-7. PubMed ID: 452602
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M, Kettler R, Zürcher G, Schaffner R, Haefely WE.
    Eur Neurol; 1987 May 11; 27 Suppl 1():9-20. PubMed ID: 3123242
    [Abstract] [Full Text] [Related]

  • 5. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA, Mattern C, Häcker R, Tomaz C, Huston JP, Schwarting RK.
    Synapse; 1997 Dec 11; 27(4):294-302. PubMed ID: 9372552
    [Abstract] [Full Text] [Related]

  • 6. [Comparative studies of L-DOPA alone and combination with a peripheral DOPA decarboxylase inhibitor, benserazide-HCl, on Parkinson's disease--Part II: Pharmacokinetic study (author's transl)].
    Yokochi M, Kondo T, Hirayama K, Narabayashi H, Kuruma I.
    No To Shinkei; 1979 Apr 11; 31(4):339-48. PubMed ID: 454549
    [No Abstract] [Full Text] [Related]

  • 7. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].
    Eichhorn TE, Schrag A, Trenkwalder C, Selzer R, Kohnen R, Oertel WH, Poewe W.
    Nervenarzt; 1995 Dec 11; 66(12):933-41. PubMed ID: 8584079
    [Abstract] [Full Text] [Related]

  • 8. Patient benefits of l-dopa and a decarboxylase inhibitor in the treatment of Parkinson's disease in elderly patients.
    Admani AK, Verma S, Cordingley GJ, Harris RI.
    Pharmatherapeutica; 1985 Dec 11; 4(2):132-40. PubMed ID: 4059292
    [Abstract] [Full Text] [Related]

  • 9. [Combined treatment of Parkinsonism with L-dopa and peripheral dopa decarboxylase inhibitors--clinical course of 13 cases and levels of serum/dopa and dopamine].
    Mizuno Y, Yoshida M, Obayashi T, Ueki A.
    Rinsho Shinkeigaku; 1976 Jul 01; 16(7):511-9. PubMed ID: 986921
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuations.
    Poewe WH, Lees AJ, Stern GM.
    Eur Neurol; 1987 Jul 01; 27 Suppl 1():93-7. PubMed ID: 3322842
    [Abstract] [Full Text] [Related]

  • 11. Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. I. Effect on O-methylated metabolites of L-dopa-2- 14 C.
    Messiha FS, Hsu TH, Bianchine JR.
    J Clin Invest; 1972 Feb 01; 51(2):452-5. PubMed ID: 5009125
    [Abstract] [Full Text] [Related]

  • 12. [L-dopa/benserazide during pregnancy in a patient with juvenile parkinsonism].
    Arai H, Shinotoh H, Hattori T.
    Rinsho Shinkeigaku; 1997 Mar 01; 37(3):264-5. PubMed ID: 9217430
    [Abstract] [Full Text] [Related]

  • 13. Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.
    Tayarani-Binazir KA, Jackson MJ, Strang I, Jairaj M, Rose S, Jenner P.
    Behav Pharmacol; 2012 Apr 01; 23(2):126-33. PubMed ID: 22236652
    [Abstract] [Full Text] [Related]

  • 14. L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment.
    Bergonzi P, Chiurulla C, Gambi D, Mennuni G, Pinto F.
    Acta Neurol Belg; 1975 Apr 01; 75(1):5-10. PubMed ID: 1202895
    [Abstract] [Full Text] [Related]

  • 15. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease].
    Dessibourg CA, Gachoud JP.
    Praxis (Bern 1994); 1995 Oct 24; 84(43):1235-8. PubMed ID: 7481341
    [Abstract] [Full Text] [Related]

  • 16. [Comparative studies of L-DOPA alone and combination with a peripheral DOPA decarboxylase inhibitor, HCL-benserazide, on Parkinson's disease-part I: clinical aspects (author's transl)].
    Yokochi M, Kondo T, Hirayama K, Narabayashi H, Kuruma I.
    No To Shinkei; 1979 Mar 24; 31(3):295-304. PubMed ID: 444336
    [No Abstract] [Full Text] [Related]

  • 17. Contrasting effects of peripheral decarboxylase inhibitors on plasma activity of aromatic-L-amino acid decarboxylase and semicarbazide-sensitive amine oxidase in Parkinson's disease.
    Boomsma F, van den Meiracker A, Man in 't Veld A, Schalekamp M.
    Life Sci; 1995 Mar 24; 57(19):1753-9. PubMed ID: 7475917
    [Abstract] [Full Text] [Related]

  • 18. [The L-dopa test in Parkinson's disease].
    Esteguy M, Bonnet AM, Kefalos J, Lhermitte F, Agid Y.
    Rev Neurol (Paris); 1985 Mar 24; 141(5):413-5. PubMed ID: 4048732
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
    Streifler M, Vardi J, Kesten M.
    Harefuah; 1972 Nov 01; 83(9):362-4. PubMed ID: 4669737
    [No Abstract] [Full Text] [Related]

  • 20. Treating parkinsonism with L-dopa and carboxylase inhibitor.
    Shau-Fong K, Ho YM.
    Mod Med Asia; 1977 Sep 01; 13(9):23-5. PubMed ID: 600260
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.